Study Evaluating Venlafaxine Extended Release in Elderly Depressed Patients
In this study we will assess as a primary objective the effect of venlafaxine retard treatment on primary care attended elderly patients with depressive syndrome. We will also study secondarily its effects on anxiety, somatic and painful symptoms of depression.
|Study Design:||Observational Model: Case-Only
Time Perspective: Prospective
|Official Title:||Vandral Retard (Venlafaxine Extended Release) in Depressive Syndrome With Anxiety and Painful Symptoms in Elderly Patients. Observational Study in Primary Care|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00247429
|Principal Investigator:||Medical Monitor||Wyeth is now a wholly owned subsidiary of Pfizer|